Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism

Drug Metabolism Reviews

Volumn 36, Issue 2, 2004, Pages 279-299

  Vasillou, Vasilis ^a   Pappa, Aglaia ^a   Estey, Tia ^a  

^a UNIVERSITY OF COLORADO   (United States)

Author keywords

Aldehyde dehydrogenases; Human; Lipid peroxidation; Metabolism; Polymorphisms

Indexed keywords

4 AMINOBUTYRIC ACID; ALCOHOL; ALDEHYDE; ALDEHYDE DEHYDROGENASE; AMINO ACID; CARBOHYDRATE; CYCLOPHOSPHAMIDE; DRUG; FOLIC ACID; LIPID; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; RETINOIC ACID;

4 AMINOBUTYRIC ACID METABOLISM; ALCOHOL METABOLISM; ALDH GENE; AMINO ACID METABOLISM; CARBOHYDRATE METABOLISM; CONFERENCE PAPER; DRUG METABOLISM; DRUG SYNTHESIS; FOLATE METABOLISM; GENE; GENE MUTATION; GENOME; INBORN ERROR OF METABOLISM; LIPID METABOLISM; LIPID PEROXIDATION; XENOBIOTIC METABOLISM;

ALDEHYDE DEHYDROGENASE; ALDEHYDES; AMINO ACIDS; ANIMALS; ANTINEOPLASTIC AGENTS, ALKYLATING; CYCLOPHOSPHAMIDE; ETHANOL; FATTY ACIDS; FOLIC ACID; GAMMA-AMINOBUTYRIC ACID; HUMANS; LIPID PEROXIDATION; TRETINOIN; XENOBIOTICS;

EID: 3042551383     PISSN: 03602532     EISSN: None     Source Type: Journal    
DOI: 10.1081/DMR-120034001     Document Type: Conference Paper

References (117)

1. Alary, J., Gueraud, F., Cravedi, J. P. (2003a). Fate of 4-hydroxynonenal in vivo: disposition and metabolic pathways. Mol. Aspects Med. 24(4-5):177-187.
2. Alary, J., Fernandez, Y., Debrauwer, L., Perdu, E., Gueraud, F. (2003b). Identification of intermediate pathways of 4-hydroxynonenal metabolism in the rat. Chem. Res. Toxicol. 16(3):320-327.
3. Ambroziak, W., Pietruszko, R. (1987). Human aldehyde dehydrogenase: metabolism of putrescine and histamine. Alcohol., Clin. Exp. Res. 11(6):528-532.
4. Ambroziak, W., Pietruszko, R. (1991). Human aldehyde dehydrogenase. Activity with aldehyde metabolites of monoamines, diamines, and polyamines. J. Biol. Chem. 266(20):13011-13018.
5. Ambroziak, W., Izaguirre, G., Pietruszko, R. (1999). Metabolism of retinaldehyde and other aldehydes in soluble extracts of human liver and kidney. J. Biol. Chem. 274 (47):33366-33373.
6. Ang, H. L., Duester, G. (1999). Retinoic acid biosynthetic enzyme ALDH1 localizes in a subset of retinoid-dependent tissues during xenopus development. Dev. Dyn. 215 (3):264-272.
7. Awasthi, S., Srivatava, S. K., Piper, J. T., Singhal, S. S., Chaubey, M., Awasthi, Y. C. (1996). Curcumin protects against 4-hydroxy-2-trans-nonenal- induced cataract formation in rat lenses. Am. J. Clin. Nutr. 64(5):761-766.
8. Baumgartner, M. R., Hu, C. A., Almashanu, S., Steel, G., Obie, C., Aral, B., Rabier, D., Kamoun, P., Saudubray, J. M., Valle, D. (2000). Hyperammonemia with reduced omithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum. Mol. Genet. 9(19):2853-2858.
9. Berggren, K., McCaffery, P., Drager, U., Forehand, C. J. (1999). Differential distribution of retinoic acid synthesis in the chicken embryo as determined by immunolocalization of the retinoic acid synthetic enzyme, RALDH-2. Dev. Biol. 210(2):288-304.
10. Borman, L. S., Branda, R. F. (1989). Nutritional folate deficiency in Chinese hamster ovary cells. I. Characterization of the pleiotropic response and its modulation by nucleic acid precursors. J. Cell. Physiol. 140(2):335-343.
11. Bunting, K. D., Townsend, A. J. (1996). Protection by transfected rat or human class 3 aldehyde dehydrogenase against the cytotoxic effects of oxazaphosphorine alkylating agents in hamster V79 cell lines. Demonstration of aldophosphamide metabolism by the human cytosolic class 3 isozyme. J. Biol. Chem. 271 (20):11891-11896.
12. Bunting, K. D., Lindahl, R., Townsend, A. J. (1994). Oxazaphosphorine- specific resistance in human MCF-7 breast carcinoma cell lines expressing transfected rat class 3 aldehyde dehydrogenase. J. Biol. Chem. 269(37):23197-23203.
13. Butterfield, D. A., Drake, J., Pocernich, C., Castegna, A. (2001). Evidence of oxidative damage in Alzheimer's disease brain: central role for amyloid beta-peptide. Trends Mol. Med. 7(12):548-554.
14. Chambliss, K. L., Gibson, K. M. (1992). Succinic semialdehyde dehydrogenase from mammalian brain: subunit analysis using polyclonal antiserum. Int. J. Biochem. 24 (9):1493-1499.
15. Chambliss, K. L., Gray, R. G., Rylance, G., Pollitt, R. J., Gibson, K. M. (2000). Molecular characterization of methylmalonate semialdehyde dehydrogenase deficiency. J. Inherit. Metab. Dis. 23(5):497-504.
16. Champion, K. M., Cook, R. J., Tollaksen, S. L., Giometti, C. S. (1994). Identification of a heritable deficiency of the folate-dependent enzyme 10-formyltetrahydrofolate dehydrogenase in mice. Proc. Natl. Acad. Sci. U. S. A. 91(24):11338-11342.
17. Chan, W. M., Tang, W. K., Cheng, C. H., Fong, W. P. (2003). Purification, N-terminal sequence determination and enzymatic characterization of antiquitin from the liver of grass carp. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 136(3):443-450.
18. Chao, Y. C., Liou, S. R., Chung, Y. Y., Tang, H. S., Hsu, C. T., Li, T. K., Yin, S. J. (1994). Polymorphism of alcohol and aldehyde dehydrogenase genes and alcoholic cirrhosis in Chinese patients. Hepatology 19(2):360-366.
19. Chern, M. K., Pietruszko, R. (1995). Human aldehyde dehydrogenase E3 isozyme is a betaine aldehyde dehydrogenase. Biochem. Biophys. Res. Commun. 213(2):561-568.
20. Cook, R. J., Lloyd, R. S., Wagner, C. (1991). Isolation and characterization of cDNA clones for rat liver 10-formyltetrahydrofolate dehydrogenase. J. Biol. Chem. 266 (8):4965-4973.
21. De Laurenzi, V., Rogers, G. R., Hamrock, D. J., Marekov, L. N., Steinert, P. M., Compton, J. G., Markova, N., Rizzo, W. B. (1996). Sjögren-Larsson syndrome is caused by mutations in the fatty aldehyde dehydrogenase gene. Nat. Genet. 12(1):52-57.
22. Demozay, D., Rocchi, S., Mas, J. C., Grillo, S., Pirola, L., Chavey, C., Van Obberghen, E. (2003). Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin. J. Biol. Chem. 279(8):6261-6270.
23. Dib, M., Garrel, C., Favier, A., Robin, V., Desnuelle, C. (2002). Can malondialdehyde be used as a biological marker of progression in neurodegenerative disease? J. Neurol. 249(4):367-374.
24. Dockham, P. A., Lee, M. O., Sladek, N. E. (1992). Identification of human liver aldehyde dehydrogenases that catalyze the oxidation of aldophosphamide and retinaldehyde. Biochem. Pharmacol. 43(11):2453-2469.
25. Duester, G. (2000). Families of retinoid dehydrogenases regulating vitamin A function: production of visual pigment and retinoic acid. Eur. J. Biochem. 267(14):4315-4324.
26. Dupe, V., Matt, N., Garnier, J. M., Chambon, P., Mark, M., Ghyselinck, N. B. (2003). A newborn lethal defect due to inactivation of retinaldehyde dehydrogenase type 3 is prevented by maternal retinoic acid treatment. Proc. Natl. Acad. Sci. U. S. A. 100 (24):14036-14041.
27. el Akawi, Z., Napoli, J. L. (1994). Rat liver cytosolic retinal dehydrogenase: comparison of 13-cis-, 9-cis-, and all-trans-retinal as substrates and effects of cellular retinoid-binding proteins and retinoic acid on activity. Biochemistry 33(7):1938-1943.
28. Enomoto, N., Takase, S., Takada, N., Takada, A. (1991). Alcoholic liver disease in heterozygotes of mutant and normal aldehyde dehydrogenase-2 genes. Hepatology 13(6):1071-1075.
29. Eriksson, C. J. (2001). The role of acetaldehyde in the actions of alcohol (update 2000). Alcohol., Clin. Exp. Res. 25(5 suppl. ISBRA):15S-32S.
30. Esterbauer, H., Schaur, R. J., Zollner, H. (1991). Chemistry and biochemistry of 4-hydroxynonenal malondialdehyde and related aldehydes. Free Radic. Biol. Med. 11:81-128.
31. Fan, X., Molotkov, A., Manabe, S., Donmoyer, C. M., Deltour, L., Foglio, M. H., Cuenca, A. E., Blaner, W. S., Lipton, S. A., Duester, G. (2003). Targeted disruption of Aldh1a1 (Raldh1) provides evidence for a complex mechanism of retinoic acid synthesis in the developing retina. Mol. Cell. Biol. 23(13):4637-4648.
32. Farrant, R. D., Walker, V., Mills, G. A., Mellor, J. M., Langley, G. J. (2001). Pyridoxal phosphate de-activation by pyrroline-5-carboxylic acid. Increased risk of vitamin B6 deficiency and seizures in hyperprolinemia type II. J. Biol. Chem. 276(18): 15107-15116.
33. Gibson, K. M., Hoffmann, G. F., Hodson, A. K., Bottiglieri, T., Jakobs, C. (1998). 4-Hydroxybutyric acid and the clinical phenotype of succinic semialdehyde dehydrogenase deficiency, an inborn error of GABA metabolism. Neuropediatrics 29(1):14-22.
34. Goedde, H. W., Agarwal, D. P. (1990). Pharmacogenetics of aldehyde dehydrogenase (ALDH). Pharmacol. Ther. 45(3):345-371.
35. Goedde, H. W., Agarwal, D. P., Fritze, G., Meier-Tackmann, D., Singh, S., Beckmann, G., Bhatia, K., Chen, L. Z., Fang, B., Lisker, R. (1992). Distribution of ADH2 and ALDH2 genotypes in different populations. Hum. Genet. 88(3):344-346.
36. Grun, F., Hirose, Y., Kawauchi, S., Ogura, T., Umesono, K. (2000). Aldehyde dehydrogenase 6, a cytosolic retinaldehyde dehydrogenase prominently expressed in sensory neuroepithelia during development. J. Biol. Chem. 275(52):41210-41218.
37. Gupta, M., Greven, R., Jansen, E. E., Jakobs, C., Hogema, B. M., Froestl, W., Snead, O. C., Bartels, H., Grompe, M., Gibson, K. M. (2002). Therapeutic intervention in mice deficient for succinate semialdehyde dehydrogenase (gamma-hydroxybutyric aciduria). J. Pharmacol. Exp. Ther. 302(1):180-187.
38. Haselbeck, R. J., Hoffmann, I., Duester, G. (1999). Distinct functions for Aldh1 and Raldh2 in the control of ligand production for embryonic retinoid signaling pathways. Dev. Genet. 25(4):353-364.
39. Hashimoto, Y., Nakayama, T., Futamura, A., Omura, M., Nakarai, H., Nakahara, K. (2002). Relationship between genetic polymorphisms of alcohol-metabolizing enzymes and changes in risk factors for coronary heart disease associated with alcohol consumption. Clin. Chem. 48(7):1043-1048.
40. Haynes, R. L., Szweda, L., Pickin, K., Welker, M. E., Townsend, A. J. (2000). Structure-activity relationships for growth inhibition and induction of apoptosis by 4-hydroxy-2-nonenal in raw 264.7 cells. Mol. Pharmacol. 58(4):788-794.
41. Hjelle, J. J., Petersen, D. R. (1983). Metabolism of malondialdehyde by rat liver aldehyde dehydrogenase. Toxicol. Appl. Pharmacol. 70(1):57-66.
42. Hogema, B. M., Gupta, M., Senephansiri, H., Burlingame, T. G., Taylor, M., Jakobs, C., Schutgens, R. B., Froestl, W., Snead, O. C., Diaz-Arrastia, R., Bottiglieri, T., Grompe, M., Gibson, K. M. (2001). Pharmacologic rescue of lethal seizures in mice deficient in succinate semialdehyde dehydrogenase. Nat. Genet. 29(2):212-216.
43. Hsu, L. C., Chang, W. C., Yoshida, A. (1997). Human aldehyde dehydrogenase genes, ALDH7 and ALDH8: genomic organization and gene structure comparison. Gene 189(1):89-94.
44. Ingelman-Sundberg, M., Daly, A. K., Oscarson, M., Nebert, D. W. (2000). Human cytochrome P450 (CYP) genes: recommendations for the nomenclature of alleles. Pharmacogenetics 10(1):91-93.
45. Jester, J. V., Moller-Pedersen, T., Huang, J., Sax, C. M., Kays, W. T., Cavangh, H. D., Petroll, W. M., Piatigorsky, J. (1999). The cellular basis of corneal transparency: evidence for 'corneal crystallins'. J. Cell. Sci. 112(Pt. 5):613-622.
46. Karnino, K., Nagasaka, K., Imagawa, M., Yamamoto, H., Yoneda, H., Ueki, A., Kitamura, S., Namekata, K., Miki, T., Ohta, S. (2000). Deficiency in mitochondrial aldehyde dehydrogenase increases the risk for late-onset Alzheimer's disease in the Japanese population. Biochem. Biophys. Res. Commun. 273(1):192-196.
47. Kama, E., Miltyk, W., Wolczynski, S., Palka, J. A. (2001). The potential mechanism for glutamine-induced collagen biosynthesis in cultured human skin fibroblasts. Comp. Biochem. Physiol., Part B Biochem. Mol. Biol. 130(1):23-32.
48. Kelson, T. L., Secor, M. Jr., Rizzo, W. B. (1997). Human liver fatty aldehyde dehydrogenase: microsomal localization, purification, and biochemical characterization. Biochim. Biophys. Acta 1335(1-2):99-110.
49. Krupenko, S. A., Oleinik, N. V. (2002). 10-Formyltetrahydrofolate dehydrogenase, one of the major folate enzymes, is down-regulated in tumor tissues and possesses suppressor effects on cancer cells. Cell Growth Differ. 13(5):227-236.
50. Krupenko, S. A., Wagner, C., Cook, R. J. (1997). Domain structure of rat 10-formyltetrahydrofolate dehydrogenase. Resolution of the amino-terminal domain as 10-formyltetrahydrofolate hydrolase. J. Biol. Chem. 272(15):10273-10278.
51. Lin, M., Napoli, J. L. (2000). cDNA cloning and expression of a human aldehyde dehydrogenase (ALDH) active with 9-cis-retinal and identification of a rat ortholog, ALDH12. J. Biol. Chem. 275(51):40106-40112.
52. Lin, M., Zhang, M., Abraham, M., Smith, S. M., Napoli, J. L. (2003). Mouse retinal dehydrogenase 4 (RALDH4), molecular cloning, cellular expression, and activity in 9-cis-retinoic acid biosynthesis in intact cells. J. Biol. Chem. 278(11):9856-9861.
53. Manzer, R., Qamar, L., Estey, T., Pappa, A., Petersen, D. R., Vasiliou, V. (2003). Molecular cloning and baculovirus expression of the rabbit corneal aldehyde dehydrogenase (ALDH1A1) cDNA. DNA Cell Biol. 22(5):329-338.
54. Maxwell, S. A., Davis, G. E. (2000). Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines. Proc. Natl. Acad. Sci. U. S. A. 97(24):13009-13014.
55. Miltyk, W., Palka, J. A. (2000). Potential role of pyrroline 5-carboxylate in regulation of collagen biosynthesis in cultured human skin fibroblasts. Comp. Biochem. Physiol., Part A Mol. Integr. Physiol. 125(2):265-271.
56. Mitchell, D. Y., Petersen, D. R. (1987). The oxidation of alpha-beta unsaturated aldehydic products of lipid peroxidation by rat liver aldehyde dehydrogenases. Toxicol. Appl. Pharmacol. 87(3):403-410.
57. Murphy, T. C., Amarnath, V., Gibson, K. M., Picklo, M. J. Sr. (2003). Oxidation of 4-hydroxy-2-nonenal by succinic semialdehyde dehydrogenase (ALDH5A). J. Neurochem. 86(2):298-305.
58. Muto, M., Hitorni, Y., Ohtsu, A., Ebihara, S., Yoshida, S., Esumi, H. (2000). Association of aldehyde dehydrogenase 2 gene polymorphism with multiple oesophageal dysplasia in head and neck cancer patients. Gut 47(2):256-261.
59. Niederreither, K., McCaffery, P., Drager, U. C., Chambon, P., Dolle, P. (1997). Restricted expression and retinoic acid-induced downregulation of the retinaldehyde dehydrogenase type 2 (RALDH-2) gene during mouse development. Mech. Dev. 62(1):67-78.
60. Niederreither, K., Subbarayan, V., Dolle, P., Chambon, P. (1999). Embryonic retinoic acid synthesis is essential for early mouse post-implantation development. Nat. Genet. 21(4):444-448.
61. Niederreither, K., Vermot, J., Schuhbaur, B., Chambon, P., Dolle, P. (2000). Retinoic acid synthesis and hindbrain patterning in the mouse embryo. Development 127 (1):75-85.
62. Nishiguchi, M., Kinoshita, H., Mostofa, J., Taniguchi, T., Ouchi, H., Minami, T., Hatake, K., Utsumi, T., Motomura, H., Hishida, S. (2002). Different blood acetaldehyde concentration following ethanol administration in a newly developed high alcohol preference and low alcohol preference rat model system. Alcohol Alcohol. 37 (1):9-12.
63. Ohsawa, I., Nishimaki, K., Yasuda, C., Kamino, K., Ohta, S. (2003). Deficiency in a mitochondrial aldehyde dehydrogenase increases vulnerability to oxidative stress in PC12 cells. J. Neurochem. 84(5):1110-1117.
64. Ohta, S. (2000). Roles of mitochondrial dysfunctions in Alzheimer's disease-contribution of deficiency of ALDH 2. Rinsho Shinkeigaku 40(12):1231-1233.
65. Oleinik, N. V., Krupenko, S. A. (2003). Ectopic expression of 10-formyltetrahydrofolate dehydrogenase in a549 cells induces g(1) cell cycle arrest and apoptosis. Mol. Cancer Res. 1(8):577-588.
66. Pappa, A., Estey, T., Manzer, R., Brown, D., Vasiliou, V. (2003a). Human aldehyde dehydrogenase 3A1 (ALDH3A1): biochemical characterization and immunohistochemical localization in the cornea. Biochem. J. 376(Pt. 3):615-623.
67. Pappa, A., Chen, C., Koutalos, Y., Townsend, A. J., Vasiliou, V. (2003b). Aldh3a1 protects human corneal epithelial cells from ultraviolet- and 4-hydroxy-2-nonenal-induced oxidative damage. Free Radic. Biol. Med. 34(9):1178-1189.
68. Parekh, H. K., Sladek, N. E. (1993). NADPH-dependent enzyme-catalyzed reduction of aldophosphamide, the pivotal metabolite of cyclophosphamide. Biochem. Pharmacol. 46(6):1043-1052.
69. Pearl, P. L., Gibson, K. M., Acosta, M. T., Vezina, L. G., Theodore, W. H., Rogawski, M. A., Novotny, E. J., Gropman, A., Conry, J. A., Berry, G. T., Tuchman, M. (2003). Clinical spectrum of succinic semialdehyde dehydrogenase deficiency. Neurology 60(9):1413-1417.
70. Picklo, M. J., Olson, S. J., Markesbery, W. R., Montine, T. J. (2001). Expression and activities of aldo-keto oxidoreductases in Alzheimer disease. J. Neuropathol. Exp. Neurol. 60(7):686-695.
71. Reichard, J. F., Vasiliou, V., Petersen, D. R. (2000). Characterization of 4-hydroxy-2-nonenal metabolism in stellate cell lines derived from normal and cirrhotic rat liver. Biochim. Biophys. Acta 1487(2-3):222-232.
72. Rekha, G. K., Devaraj, V. R., Sreerama, L., Lee, M. J., Nagasawa, H. T., Sladek, N. E. (1998). Inhibition of human class 3 aldehyde dehydrogenase, and sensitization of tumor cells that express significant amounts of this enzyme to oxazaphosphorines, by chlorpropamide analogues. Biochem. Pharmacol. 55(4):465-474.
73. Ren, S., Yang, J. S., Kalhorn, T. F., Slattery, J. T. (1997). Oxidation of cyclophosphamide to 4-hydroxycyclophosphamide and deschloroethylcyclophosphamide in human liver microsomes. Cancer Res. 57(19):4229-4235.
74. Reuland, S. N., Vlasov, A. P., Krupenko, S. A. (2003). Disruption of a calmodulin central helix-like region of 10-formyltetrahydrofolate dehydrogenase impairs its dehydrogenase activity by uncoupling the functional domains. J. Biol. Chem. 278 (25):22894-22900.
75. Rizzo, W. B., Carney, G., Liu, Z. (1999). The molecular basis of Sjögren-Larsson syndrome: mutation analysis of the fatty aldehyde dehydrogenase gene. Am. J. Hum. Genet. 65(6):1547-1560.
76. Roe, C. R., Struys, E., Kok, R. M., Roe, D. S., Harris, R. A., Jakobs, C. (1998). Methylmalonic semialdehyde dehydrogenase deficiency: psychomotor delay and methylmalonic aciduria without metabolic decompensation. Mol. Genet. Metab. 65 (1):35-43.
77. Saito, K., Yokoyama, T., Yoshiike, N., Date, C., Yamamoto, A., Muramatsu, M., Tanaka, H. (2003). Do the ethanol metabolizing enzymes modify the relationship between alcohol consumption and blood pressure? J. Hypertens. 21(6):1097-1105.
78. Sayre, L. M., Smith, M. A., Perry, G. (2001). Chemistry and biochemistry of oxidative stress in neurodegenerative disease. Curr. Med. Chem. 8(7):721-738.
79. Siu, G. M., Draper, H. H. (1982). Metabolism of malonaldehyde in vivo and in vitro. Lipids 17(5):349-355.
80. Skvorak, A. B., Robertson, N. G., Yin, Y., Weremowicz, S., Her, H., Bieber, F. R., Beisel, K. W., Lynch, E. D., Beier, D. R., Morton, C. C. (1997). An ancient conserved gene expressed in the human inner ear: identification, expression analysis, and chromosomal mapping of human and mouse antiquitin (ATQ1). Genomics 46(2):191-199.
81. Sladek, N. E. (1999). Aldehyde dehydrogenase-mediated cellular relative insensitivity to the oxazaphosphorines. Curr. Pharm. Des. 5(8):607-625.
82. Sophos, N. A., Vasiliou, V. (2003). Aldehyde dehydrogenase gene superfamily: the 2002 update. Chem. Biol. Interact. 143-144:5-22.
83. Sophos, N. A., Pappa, A., Ziegler, T. L., Vasiliou, V. (2001). Aldehyde dehydrogenase gene superfamily: the 2000 update. Chem. Biol. Interact. 130-132(1-3):323-337.
84. Spence, J. P., Liang, T., Eriksson, C. J., Taylor, R. E., Wall, T. L., Ehlers, C. L., Carr, L. G. (2003). Evaluation of aldehyde dehydrogenase 1 promoter polymorphisms identified in human populations. Alcohol., Clin. Exp. Res. 27(9):1389-1394.
85. Sreerama, L., Rekha, G. K., Sladek, N. E. (1995). Phenolic antioxidant-induced overexpression of class-3 aldehyde dehydrogenase and oxazaphosphorine-specific resistance. Biochem. Pharmacol. 49(5):669-675.
86. Stewart, M. J., Malek, K., Xiao, Q., Dipple, K. M., Crabb, D. W. (1995). The novel aldehyde dehydrogenase gene, ALDH5, encodes an active aldehyde dehydrogenase enzyme. Biochem. Biophys. Res. Commun. 211(1):144-151.
87. Swindell, E. C., Thaller, C., Sockanathan, S., Petkovich, M., Jessell, T. M., Eichele, G. (1999). Complementary domains of retinoic acid production and degradation in the early chick embryol. Dev. Biol. 216(1):282-296.
88. Tang, W. K., Cheng, C. H., Fong, W. P. (2002). First purification of the antiquitin protein and demonstration of its enzymatic activity. FEBS Lett. 516(1-3):183-186.
89. Thukkani, A. K., McHowat, J., Hsu, F. F., Brennan, M. L., Hazen, S. L., Ford, D. A. (2003). Identification of alpha-chloro fatty aldehydes and unsaturated lysophosphatidylcholine molecular species in human atherosclerotic lesions. Circulation 108(25):3128-3133.
90. Totan, Y., Cekic, O., Borazan, M., Uz, E., Sogut, S., Akyol, O. (2001). Plasma malondialdehyde and nitric oxide levels in age related macular degeneration. Br. J. Ophthalmol. 85(12):1426-1428.
91. Townsend, A. J., Leone-Kabler, S., Haynes, R. L., Wu, Y., Szweda, L., Bunting, K. D. (2001). Selective protection by stably transfected human ALDH3A1 (but not human ALDH1A1) against toxicity of aliphatic aldehydes in V79 cells. Chem. Biol. Interact. 130-132(1-3):261-273.
92. Traverso, N., Menini, S., Odetti, P., Pronzato, M. A., Cottalasso, D., Marinari, U. M. (1999). Lipoperoxidation in hepatic subcellular compartments of diabetic rats. Free Radic. Biol. Med. 26(5-6):538-547.
93. Traverso, N., Menini, S., Odetti, P., Pronzato, M. A., Cottalasso, D., Marinari, U. M. (2002). Diabetes impairs the enzymatic disposal of 4-hydroxynonenal in rat liver. Free Radic. Biol. Med. 32(4):350-359.
94. Ueshima, Y., Matsuda, Y., Tsutsumi, M., Takada, A. (1993). Role of the aldehyde dehydrogenase-1 isozyme in the metabolism of acetaldehyde. Alcohol Alcohol., Suppl. 1B:15-19.
95. Valle, D., Goodman, S. I., Applegarth, D. A., Shih, V. E., Phang, J. M. (1976). Type II hyperprolinemia. Delta1-pyrroline-5-carboxylic acid dehydrogenase deficiency in cultured skin fibroblasts and circulating lymphocytes. J. Clin. Invest. 58(3):598-603.
96. Vasiliou, V., Pappa, A. (2000). Polymorphisms of human aldehyde dehydrogenases. Consequences for drug metabolism and disease. Pharmacology 61(3):192-198.
97. Vasiliou, V., Puga, A., Nebert, D. W. (1992). Negative regulation of the murine cytosolic aldehyde dehydrogenase-3 (Aldh-3c) gene by functional CYP1A1 and CYP1A2 proteins. Biochem. Biophys. Res. Commun. 187(1):413-419.
98. Vasiliou, V., Shertzer, H. G., Liu, R. M., Sainsbury, M., Nebert, D. W. (1995). Response of [Ah] battery genes to compounds that protect against menadione toxicity. Biochem. Pharmacol. 50(11):1885-1891.
99. Vasiliou, V., Bairoch, A., Tipton, K. F., Nebert, D. W. (1999). Eukaryotic aldehyde dehydrogenase (ALDH) genes: human polymorphisms, and recommended nomenclature based on divergent evolution and chromosomal mapping. Pharmacogenetics 9(4):421-434.
100. Vasiliou, V., Pappa, A., Petersen, D. R. (2000). Role of aldehyde dehydrogenases in endogenous and xenobiotic metabolism. Chem. Biol. Interact. 129(1-2):1-19.
101. Vaz, F. M., Fouchier, S. W., Ofman, R., Sommer, M., Wanders, R. J. (2000). Molecular and biochemical characterization of rat gamma- trimethylaminobutyraldehyde dehydrogenase and evidence for the involvement of human aldehyde dehydrogenase 9 in camitine biosynthesis. J. Biol. Chem. 275(10):7390-7394.
102. Vermot, J., Niederreither, K., Garnier, J. M., Chambon, P., Dolle, P. (2003). Decreased embryonic retinoic acid synthesis results in a DiGeorge syndrome phenotype in newborn mice. Proc. Natl. Acad. Sci. U. S. A. 100(4):1763-1768.
103. Wang, X., Penzes, P., Napoli, J. L. (1996). Cloning of a cDNA encoding an aldehyde dehydrogenase and its expression in Escherichia coli. Recognition of retinal as substrate. J. Biol. Chem. 271(27):16288-16293.
104. Willemsen, M. A., Rotteveel, J. J., van Domburg, P. H., Gabreels, F. J., Mayatepek, E., Sengers, R. C. (1999). Preterm birth in Sjögren-Larsson syndrome. Neuropediatrics 30(6):325-327.
105. Willemsen, M. A., IJlst, L., Steijlen, P. M., Rotteveel, J. J., de Jong, J. G., van Domburg, P. H., Mayatepek, E., Gabreels, F. J., Wanders, R. J. (2001). Clinical, biochemical and molecular genetic characteristics of 19 patients with the Sjögren-Larsson syndrome. Brain 124(Pt. 7):1426-1437.
106. Witztum, J. L. (1994). The oxidation hypothesis of atherosclerosis. Lancet 344(8925): 793-795.
107. Xiao, C., Xin, H., Dong, A., Sun, C., Cao, K. (1999). A novel calmodulin-like protein gene in rice which has an unusual prolonged C-terminal sequence carrying a putative prenylation site. DNA Res. 6(3):179-181.
108. Yamada, Y., Sun, F., Tsuritani, I., Honda, R. (2002). Genetic differences in ethanol metabolizing enzymes and blood pressure in Japanese alcohol consumers. J. Hum. Hypertens. 16(7):479-486.
109. Yeh, G. C., Roth, E. F. Jr., Phang, J. M., Harris, S. C., Nagel, R. L., Rinaldi, A. (1984). The effect of pyrroline-5-carboxylic acid on nucleotide metabolism in erythrocytes from normal and glucose-6-phosphate dehydrogenase-deficient subjects. J. Biol. Chem. 259(9):5454-5458.
110. Yokoyama, A., Omori, T. (2001). Alcohol and oropharyngolaryngeal and digestive tract cancer. Nihon Arukoru, Yakubutsu Igakkai Zasshi 36(6):551-566.
111. Yokoyama, A., Muramatsu, T., Ohmori, T., Yokoyama, T., Okuyama, K., Takahashi, H., Hasegawa, Y., Higuchi, S., Maruyama, K., Shirakura, K., Ishii, H. (1998a). Alcohol-related cancers and aldehyde dehydrogenase-2 in Japanese alcoholics. Carcinogenesis 19(8):1383-1387.
112. Yokoyama, A., Ohmori, T., Muramatsu, T., Yokoyama, T., Okuyama, K., Makuuchi, H., Takahashi, H., Higuchi, S., Hayashida, M., Maruyama, K., Ishii, H. (1998b). Short-term follow-up after endoscopic mucosectomy of early esophageal cancer and aldehyde dehydrogenase-2 genotype in Japanese alcoholics. Cancer Epidemiol. Biomark. Prev. 7(6):473-476.
113. Yokoyama, A., Muramatsu, T., Omori, T., Matsushita, S., Yoshimizu, H., Higuchi, S., Yokoyama, T., Maruyama, K., Ishii, H. (1999). Alcohol and aldehyde dehydrogenase gene polymorphisms influence susceptibility to esophageal cancer in Japanese alcoholics. Alcohol., Clin. Exp. Res. 23(11):1705-1710.
114. Yokoyama, A., Muramatsu, T., Omori, T., Yokoyama, T., Matsushita, S., Higuchi, S., Maruyama, K., Ishii, H. (2001). Alcohol and aldehyde dehydrogenase gene polymorphisms and oropharyngolaryngeal, esophageal and stomach cancers in Japanese alcoholics. Carcinogenesis 22(3):433-439.
115. Yoshida, A. (1992). Molecular genetics of human aldehyde dehydrogenase. Pharmacogenetics 2(4):139-147.
116. Yoshida, A., Huang, I. Y., Ikawa, M. (1984). Molecular abnormality of an inactive aldehyde dehydrogenase variant commonly found in Orientals. Proc. Natl. Acad. Sci. U. S. A. 81(1):258-261.
117. Ziegler, T. L., Vasiliou, V. (1999). Aldehyde dehydrogenase gene superfamily. The 1998 update. Adv. Exp. Med. Biol. 463:255-263.